drugset / Trial / NCT00280657

Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa

NCT00280657

Phase 3 Completed 1326 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine safety and efficacy of an oral contraceptive in treating acne papulopustulosa.

Timeline

Start
2004-03-10
Primary completion
2005-05-21
Completion
2005-05-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule 2 mg Oral
Subject cyproterone acetate Small molecule 2 mg Oral
Subject ethinyl estradiol Small molecule 0.03 mg Oral
Subject ethinyl estradiol Small molecule 0.035 mg Oral

Indications